Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months.
作者信息
Jorgensen Sarah C J, Hernandez Alejandro, Fell Deshayne B, Austin Peter C, D'Souza Rohan, Guttmann Astrid, Kwong Jeffrey C
机构信息
Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ICES, Toronto, Ontario, Canada.
出版信息
JAMA Pediatr. 2023 Apr 1;177(4):427-430. doi: 10.1001/jamapediatrics.2022.6134.
Abstract
摘要
相似文献
1
Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months.
JAMA Pediatr. 2023 Apr 1;177(4):427-430. doi: 10.1001/jamapediatrics.2022.6134.
2
Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study.
BMJ. 2023 Feb 8;380:e074035. doi: 10.1136/bmj-2022-074035.
3
Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023.
MMWR Morb Mortal Wkly Rep. 2023 Sep 29;72(39):1057-1064. doi: 10.15585/mmwr.mm7239a3.
4
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States.
JAMA Netw Open. 2022 Sep 1;5(9):e2233273. doi: 10.1001/jamanetworkopen.2022.33273.
5
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
6
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
N Engl J Med. 2022 Jul 14;387(2):109-119. doi: 10.1056/NEJMoa2204399. Epub 2022 Jun 22.
7
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
8
Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France.
Vaccine. 2023 Mar 24;41(13):2280-2288. doi: 10.1016/j.vaccine.2023.02.062. Epub 2023 Feb 27.
9
Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants.
JAMA Intern Med. 2022 Aug 1;182(8):825-831. doi: 10.1001/jamainternmed.2022.2442.
10
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
引用本文的文献
1
Social Media Misinformation about Pregnancy and COVID-19 Vaccines: A Systematic Review.
Med Princ Pract. 2024;33(3):232-241. doi: 10.1159/000538346. Epub 2024 Mar 14.
Zotero 插件